Company / Capital Expenditures
Arcutis Biotherapeutics, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$686.0K
FY2025
5-year range
$143.0K / $995.0K
FY2021-FY2025
Trend
+379.7%
vs FY2024
Sector context
#128 of 194
Health Care
What the data says
Capital Expenditures changed +380% YoY in FY2025, a notable deviation from the 6-year average annual change of +82%.
Based on SEC 10-K filings.
$686,000 in FY2025 with a 5-year CAGR of +16.4%.
Improved from $428,000 to $686,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +27.2%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
#128 of 194 in Health CareTop 66% of 194This company $686.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 379.7% year-over-year.
- Ranks #128 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $686.0K | +379.7% |
| FY2024 | $143.0K | -66.6% |
| FY2023 | $428.0K | +28.5% |
| FY2022 | $333.0K | -66.5% |
| FY2021 | $995.0K | +210.0% |
| FY2020 | $321.0K | +8.8% |
| FY2019 | $295.0K | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026